Acquisition Details
- Acquiring Entity: Abhay Chinubhai Shah (disclosed as PAC 8 under the Open Offer)
- Target Company: Parmax Pharma Limited
- Number of Shares Acquired: 249,394 equity shares of face value ₹10.00 each
- Date of Acquisition: June 18, 2026
- Mode of Acquisition: Off-market transaction
- Purchase Price per Share: ₹35.00
Sellers and Transaction Breakdown
- Pradeep Gosalia: 249,194 shares
- Vandana Gosalia: 100 shares
- Nimit Gosalia: 100 shares
Shareholding Impact
- PAC 8 Holding After Acquisition: 249,394 shares (2.76% of total share capital)
- Total Acquirer & PAC Holding Before Acquisition: 768,320 shares (20.54% of total share capital)
- Total Acquirer & PAC Holding After Acquisition: 1,017,714 shares (27.20% of total share capital)
Additional Information
- Abhay Chinubhai Shah was properly disclosed as PAC 8 in the public announcement dated June 08, 2026 and the detailed public statement published on June 15, 2026
- PAC 8 has paid the consideration amount for acquisition of the shares
- The shares are yet to be credited to the demat account of PAC 8
Parties Involved
Acquirers:
- Dhiren Chandulal Shah ("Acquirer 1")
- Sunil Chinubhai Shah ("Acquirer 2")
Persons Acting in Concert (PACs):
- Dhairya Dhiren Shah (PAC 1)
- Hiren Pravin Doshi (PAC 2)
- Sheetal Hiren Doshi (PAC 3)
- Nirmal Sunilbhai Shah (PAC 4)
- Rupa Sunil Shah (PAC 5)
- Vijaykumar Natvarlal Shiyani (PAC 6)
- Kamlesh Natvarlal Shiyani (PAC 7)
- Abhay Chinubhai Shah (PAC 8)
- Umang Alkesh Gosalia (PAC 9)
- Meena Alkesh Gosalia (PAC 10)